ONTOLOGY REPORT - ANNOTATIONS
| Term: | silicon dioxide |
|
| Accession: | CHEBI:30563
|
browse the term
|
| Definition: | A silicon oxide made up of linear triatomic molecules in which a silicon atom is covalently bonded to two oxygens. |
| Synonyms: | exact_synonym: | silicon(IV) oxide |
| | related_synonym: | (SiO2)n; InChI=1S/O2Si/c1-3-2; InChIKey=VYPSYNLAJGMNEJ-UHFFFAOYSA-N; Kieselsaeureanhydrid; O2Si; O=[Si]=O; SiO2; Siliziumdioxid; silica; silicic anhydride |
| | xref_casrn: | 7631-86-9 |
| | xref: | ChemIDplus:7631-86-9 "CAS Registry Number"; CiteXplore:8991630 "PubMed citation"; Gmelin:200274 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D012822 |
| | xref: | MolBase:887 "MolBase"; NIST Chemistry WebBook:7631-86-9 "CAS Registry Number"; Reaxys:3902804 "Reaxys Registry Number" |
|
|
silicon dioxide
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
decreases expression |
ISO |
7 |
129,542,758 |
129,591,363 |
RGD:6480464 |
CTD |
| G |
Abhd6 |
abhydrolase domain containing 6 |
|
decreases expression |
ISO |
15 |
18,846,512 |
18,894,003 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases activity |
EXP |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
decreases expression |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Aff1 |
AF4/FMR2 family, member 1 |
|
increases expression |
ISO |
14 |
7,015,191 |
7,114,671 |
RGD:6480464 |
CTD |
| G |
Agfg2 |
ArfGAP with FG repeats 2 |
|
decreases expression |
ISO |
12 |
19,716,015 |
19,752,171 |
RGD:6480464 |
CTD |
| G |
Ahcyl2 |
adenosylhomocysteinase-like 2 |
|
increases expression |
ISO |
4 |
56,654,054 |
56,801,641 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects response to substance |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akna |
AT-hook transcription factor |
|
decreases expression |
ISO |
5 |
80,329,462 |
80,368,061 |
RGD:6480464 |
CTD |
| G |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,755,871 |
61,771,264 |
RGD:6480464 |
CTD |
| G |
Aktip |
AKT interacting protein |
|
decreases expression |
ISO |
19 |
17,035,220 |
17,045,096 |
RGD:6480464 |
CTD |
| G |
Alkbh4 |
alkB, alkylation repair homolog 4 (E. coli) |
|
decreases expression |
ISO |
12 |
21,639,400 |
21,645,317 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
increases expression |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
increases expression |
EXP |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
decreases expression |
ISO |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
decreases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ankrd10 |
ankyrin repeat domain 10 |
|
decreases expression |
ISO |
16 |
82,719,075 |
82,742,218 |
RGD:6480464 |
CTD |
| G |
Ankrd49 |
ankyrin repeat domain 49 |
|
decreases expression |
ISO |
8 |
11,582,729 |
11,587,414 |
RGD:6480464 |
CTD |
| G |
Ap2a2 |
adaptor-related protein complex 2, alpha 2 subunit |
|
decreases expression |
ISO |
1 |
201,741,585 |
201,813,472 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
increases expression |
ISO |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqr |
aquarius homolog (mouse) |
|
decreases expression |
ISO |
3 |
99,964,018 |
100,034,050 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
ISO |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arf2 |
ADP-ribosylation factor 2 |
|
increases expression |
ISO |
10 |
93,114,540 |
93,136,313 |
RGD:6480464 |
CTD |
| G |
Arhgap39 |
Rho GTPase activating protein 39 |
|
decreases expression |
ISO |
7 |
114,776,991 |
114,866,861 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
decreases expression |
ISO |
6 |
72,685,231 |
72,693,052 |
RGD:6480464 |
CTD |
| G |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
decreases expression |
ISO |
16 |
2,595,636 |
2,665,051 |
RGD:6480464 |
CTD |
| G |
Arid5a |
AT rich interactive domain 5A (Mrf1 like) |
|
increases expression |
ISO |
9 |
35,239,813 |
35,244,452 |
RGD:6480464 |
CTD |
| G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
|
decreases expression |
ISO |
8 |
79,824,737 |
79,846,702 |
RGD:6480464 |
CTD |
| G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
|
decreases expression |
ISO |
17 |
77,759,058 |
77,777,760 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
decreases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
increases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
decreases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
increases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp11a |
ATPase, class VI, type 11A |
|
decreases expression |
ISO |
16 |
81,514,979 |
81,624,861 |
RGD:6480464 |
CTD |
| G |
Atp5c1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
|
decreases expression |
ISO |
17 |
79,738,999 |
79,761,176 |
RGD:6480464 |
CTD |
| G |
Atp5g2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
|
decreases expression |
ISO |
7 |
141,412,892 |
141,421,263 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked |
|
increases expression |
ISO |
X |
93,903,794 |
94,051,337 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
decreases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B3galnt2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
decreases expression |
ISO |
17 |
59,531,872 |
59,576,151 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
decreases expression |
ISO |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
|
increases expression |
ISO |
2 |
219,075,206 |
219,188,344 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
increases expression |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
decreases expression |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Birc6 |
baculoviral IAP repeat-containing 6 |
|
increases expression |
ISO |
6 |
20,655,186 |
20,848,961 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Brd2 |
bromodomain containing 2 |
|
increases expression |
ISO |
20 |
4,864,606 |
4,871,813 |
RGD:6480464 |
CTD |
| G |
Brd8 |
bromodomain containing 8 |
|
decreases expression |
ISO |
18 |
27,074,235 |
27,094,586 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
increases expression |
EXP |
14 |
72,404,263 |
72,414,500 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
increases expression |
ISO |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
increases expression |
ISO |
6 |
54,817,673 |
54,881,310 |
RGD:6480464 |
CTD |
| G |
C1d |
C1D nuclear receptor co-repressor |
|
decreases expression |
ISO |
14 |
98,153,633 |
98,166,585 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
decreases expression |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
increases expression |
ISO |
4 |
159,326,402 |
159,333,433 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
decreases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calhm2 |
calcium homeostasis modulator 2 |
|
decreases expression |
ISO |
1 |
252,454,945 |
252,460,671 |
RGD:6480464 |
CTD |
| G |
Capn7 |
calpain 7 |
|
decreases expression |
ISO |
16 |
6,784,270 |
6,820,953 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases expression |
EXP |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
decreases expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8ap2 |
caspase 8 associated protein 2 |
|
decreases expression |
ISO |
5 |
48,920,175 |
48,958,139 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbx4 |
chromobox homolog 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cbx6 |
chromobox homolog 6 |
|
decreases expression |
ISO |
7 |
118,062,267 |
118,070,004 |
RGD:6480464 |
CTD |
| G |
Cbx8 |
chromobox homolog 8 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccdc117 |
coiled-coil domain containing 117 |
|
decreases expression |
ISO |
14 |
86,161,551 |
86,170,917 |
RGD:6480464 |
CTD |
| G |
Ccdc39 |
coiled-coil domain containing 39 |
|
decreases expression |
ISO |
2 |
120,117,112 |
120,154,958 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
EXP |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
decreases expression |
ISO |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
decreases expression |
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
decreases expression |
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccl24 |
chemokine (C-C motif) ligand 24 |
|
decreases expression |
ISO |
12 |
22,255,293 |
22,259,290 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases secretion |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnj |
cyclin J |
|
decreases expression |
ISO |
1 |
245,997,221 |
246,015,024 |
RGD:6480464 |
CTD |
| G |
Ccnl1 |
cyclin L1 |
|
increases expression |
ISO |
2 |
155,757,335 |
155,769,633 |
RGD:6480464 |
CTD |
| G |
Ccnt2 |
cyclin T2 |
|
decreases expression |
ISO |
13 |
40,498,884 |
40,540,130 |
RGD:6480464 |
CTD |
| G |
Ccpg1 |
cell cycle progression 1 |
|
decreases expression |
ISO |
8 |
77,724,315 |
77,768,060 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
increases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
EXP |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr6 |
chemokine (C-C motif) receptor 6 |
|
decreases expression |
ISO |
1 |
47,115,472 |
47,139,825 |
RGD:6480464 |
CTD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
decreases expression |
ISO |
10 |
87,925,093 |
87,936,325 |
RGD:6480464 |
CTD |
| G |
Ccr8 |
chemokine (C-C motif) receptor 8 |
|
decreases expression |
ISO |
8 |
125,075,457 |
125,076,518 |
RGD:6480464 |
CTD |
| G |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
|
increases expression |
ISO |
8 |
115,451,786 |
115,454,088 |
RGD:6480464 |
CTD |
| G |
Cd200r1 |
CD200 receptor 1 |
|
decreases expression |
ISO |
11 |
57,427,237 |
57,459,716 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 molecule |
|
decreases expression |
ISO |
1 |
95,709,961 |
95,715,116 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
increases expression |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd97 |
CD97 molecule |
|
increases expression |
EXP |
19 |
26,089,268 |
26,108,997 |
RGD:6480464 |
CTD |
| G |
Cdc37l1 |
cell division cycle 37-like 1 |
|
decreases expression |
ISO |
1 |
232,624,609 |
232,652,549 |
RGD:6480464 |
CTD |
| G |
Cdk12 |
cyclin-dependent kinase 12 |
|
increases expression |
ISO |
10 |
86,972,428 |
87,027,794 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cep68 |
centrosomal protein 68 |
|
decreases expression |
ISO |
14 |
101,031,918 |
101,051,380 |
RGD:6480464 |
CTD |
| G |
Cfh |
complement factor H |
|
decreases expression |
ISO |
13 |
53,252,249 |
53,355,987 |
RGD:6480464 |
CTD |
| G |
Cfl2 |
cofilin 2, muscle |
|
decreases expression |
ISO |
6 |
75,203,408 |
75,207,425 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Chac1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
increases expression |
ISO |
3 |
105,869,762 |
105,873,332 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
increases expression |
ISO |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
decreases expression |
ISO |
7 |
25,171,417 |
25,198,384 |
RGD:6480464 |
CTD |
| G |
Chst1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
decreases expression |
ISO |
3 |
76,994,089 |
77,008,874 |
RGD:6480464 |
CTD |
| G |
Chst12 |
carbohydrate (chondroitin 4) sulfotransferase 12 |
|
decreases expression |
ISO |
12 |
14,577,440 |
14,579,051 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
decreases expression |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Clcc1 |
chloride channel CLIC-like 1 |
|
decreases expression |
ISO |
2 |
204,245,357 |
204,278,530 |
RGD:6480464 |
CTD |
| G |
Clec4d |
C-type lectin domain family 4, member D |
|
increases expression |
EXP |
4 |
159,883,556 |
159,892,609 |
RGD:6480464 |
CTD |
| G |
Clec4e |
C-type lectin domain family 4, member E |
|
increases expression |
EXP |
4 |
159,901,953 |
159,907,090 |
RGD:6480464 |
CTD |
| G |
Clec4e |
C-type lectin domain family 4, member E |
|
increases expression |
ISO |
4 |
159,901,953 |
159,907,090 |
RGD:6480464 |
CTD |
| G |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
decreases expression |
ISO |
6 |
44,128,544 |
44,139,346 |
RGD:6480464 |
CTD |
| G |
Cnnm3 |
cyclin M3 |
|
decreases expression |
ISO |
9 |
35,454,856 |
35,470,211 |
RGD:6480464 |
CTD |
| G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
decreases expression |
ISO |
5 |
154,674,754 |
154,702,552 |
RGD:6480464 |
CTD |
| G |
Col4a5 |
collagen, type IV, alpha 5 |
|
decreases expression |
ISO |
X |
36,918,697 |
37,130,659 |
RGD:6480464 |
CTD |
| G |
Coro1a |
coronin, actin binding protein 1A |
|
decreases expression |
ISO |
1 |
185,852,741 |
185,857,715 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
decreases expression |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
|
increases expression |
ISO |
10 |
15,968,782 |
16,026,700 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
ISO |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crot |
carnitine O-octanoyltransferase |
|
decreases expression |
ISO |
4 |
22,023,913 |
22,067,029 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
decreases expression |
ISO |
7 |
116,227,239 |
116,271,993 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases secretion |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Ctr9 |
Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
168,784,355 |
168,814,971 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
|
increases expression |
ISO |
2 |
200,272,402 |
200,319,448 |
RGD:6480464 |
CTD |
| G |
Ctu1 |
cytosolic thiouridylase subunit 1 homolog (S. pombe) |
|
decreases expression |
ISO |
1 |
94,083,641 |
94,089,433 |
RGD:6480464 |
CTD |
| G |
Cul2 |
cullin 2 |
|
decreases expression |
ISO |
17 |
62,701,289 |
62,741,344 |
RGD:6480464 |
CTD |
| G |
Cul3 |
cullin 3 |
|
decreases expression |
ISO |
9 |
79,574,062 |
79,634,396 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases secretion |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
increases expression |
ISO |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl13 |
chemokine (C-X-C motif) ligand 13 |
|
decreases expression |
ISO |
14 |
15,126,332 |
15,131,368 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
increases expression |
EXP |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
decreases expression |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxxc5 |
CXXC finger protein 5 |
|
decreases expression |
ISO |
18 |
28,484,230 |
28,487,485 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
increases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
decreases expression |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cytip |
cytohesin 1 interacting protein |
|
decreases expression |
ISO |
3 |
39,893,884 |
39,921,114 |
RGD:6480464 |
CTD |
| G |
Daglb |
diacylglycerol lipase, beta |
|
decreases expression |
ISO |
12 |
11,403,012 |
11,446,588 |
RGD:6480464 |
CTD |
| G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
|
decreases expression |
ISO |
2 |
235,423,487 |
235,474,068 |
RGD:6480464 |
CTD |
| G |
Dcun1d1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
122,339,553 |
122,384,815 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddx26b |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddx6 |
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
|
increases expression |
ISO |
8 |
47,573,536 |
47,605,957 |
RGD:6480464 |
CTD |
| G |
Derl2 |
Der1-like domain family, member 2 |
|
decreases expression |
ISO |
10 |
57,911,784 |
57,921,221 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
decreases expression |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dhx30 |
DEAH (Asp-Glu-Ala-His) box polypeptide 30 |
|
decreases expression |
ISO |
8 |
114,438,389 |
114,470,350 |
RGD:6480464 |
CTD |
| G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
|
decreases expression |
ISO |
4 |
21,329,397 |
21,369,691 |
RGD:6480464 |
CTD |
| G |
Dna2 |
DNA replication helicase 2 homolog (yeast) |
|
decreases expression |
ISO |
20 |
25,288,326 |
25,316,851 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajc10 |
DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
decreases expression |
ISO |
3 |
63,145,016 |
63,185,201 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
decreases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
|
decreases expression |
ISO |
13 |
107,603,353 |
107,640,812 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp16 |
dual specificity phosphatase 16 |
|
increases expression |
ISO |
4 |
171,620,395 |
171,667,593 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
increases expression |
ISO |
3 |
114,838,605 |
114,840,790 |
RGD:6480464 |
CTD |
| G |
Dusp8 |
dual specificity phosphatase 8 |
|
increases expression |
ISO |
1 |
202,215,086 |
202,229,746 |
RGD:6480464 |
CTD |
| G |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
|
decreases expression |
ISO |
13 |
44,077,971 |
44,089,140 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Efr3a |
EFR3 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
103,147,405 |
103,228,104 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
affects expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
increases expression |
ISO |
1 |
76,292,179 |
76,310,584 |
RGD:6480464 |
CTD |
| G |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
|
decreases expression |
ISO |
3 |
112,979,189 |
112,980,908 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
decreases expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
increases expression |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Eri2 |
ERI1 exoribonuclease family member 2 |
|
decreases expression |
ISO |
1 |
178,080,663 |
178,090,401 |
RGD:6480464 |
CTD |
| G |
Etaa1 |
Ewing tumor-associated antigen 1 |
|
decreases expression |
ISO |
14 |
98,807,365 |
98,822,369 |
RGD:6480464 |
CTD |
| G |
Evi5 |
ecotropic viral integration site 5 |
|
decreases expression |
ISO |
14 |
2,461,189 |
2,575,313 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
decreases expression |
ISO |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fam129b |
family with sequence similarity 129, member B |
|
increases expression |
ISO |
3 |
11,862,604 |
11,912,117 |
RGD:6480464 |
CTD |
| G |
Fam13c |
family with sequence similarity 13, member C |
|
decreases expression |
ISO |
20 |
18,850,307 |
18,977,473 |
RGD:6480464 |
CTD |
| G |
Fam149b1 |
family with sequence similarity 149, member B1 |
|
decreases expression |
ISO |
15 |
4,157,828 |
4,196,419 |
RGD:6480464 |
CTD |
| G |
Fam46c |
family with sequence similarity 46, member C |
|
increases expression |
ISO |
2 |
195,462,849 |
195,481,953 |
RGD:6480464 |
CTD |
| G |
Fam58b |
family with sequence similarity 58, member B |
|
decreases expression |
ISO |
10 |
64,864,942 |
64,866,105 |
RGD:6480464 |
CTD |
| G |
Fam76b |
family with sequence similarity 76, member B |
|
decreases expression |
ISO |
8 |
10,628,599 |
10,647,170 |
RGD:6480464 |
CTD |
| G |
Fam92a1 |
family with sequence similarity 92, member A1 |
|
decreases expression |
ISO |
5 |
26,402,199 |
26,420,568 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
affects response to substance |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbxo15 |
F-box protein 15 |
|
increases expression |
ISO |
18 |
81,542,665 |
81,599,809 |
RGD:6480464 |
CTD |
| G |
Fbxo21 |
F-box protein 21 |
|
decreases expression |
ISO |
12 |
39,719,654 |
39,753,892 |
RGD:6480464 |
CTD |
| G |
Fbxo9 |
f-box protein 9 |
|
decreases expression |
ISO |
8 |
83,056,071 |
83,081,992 |
RGD:6480464 |
CTD |
| G |
Fem1b |
fem-1 homolog b (C. elegans) |
|
increases expression |
ISO |
8 |
66,948,714 |
66,961,986 |
RGD:6480464 |
CTD |
| G |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
|
decreases expression |
ISO |
4 |
184,153,022 |
184,173,961 |
RGD:6480464 |
CTD |
| G |
Fnbp4 |
formin binding protein 4 |
|
decreases expression |
ISO |
3 |
75,111,004 |
75,141,649 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
increases expression |
EXP |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Frmd4b |
FERM domain containing 4B |
|
decreases expression |
ISO |
4 |
132,012,943 |
132,207,644 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
decreases expression |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Fus |
fused in sarcoma |
|
decreases expression |
ISO |
1 |
187,250,871 |
187,264,742 |
RGD:6480464 |
CTD |
| G |
Fyco1 |
FYVE and coiled-coil domain containing 1 |
|
decreases expression |
ISO |
8 |
128,543,895 |
128,612,184 |
RGD:6480464 |
CTD |
| G |
Fzd5 |
frizzled family receptor 5 |
|
increases expression |
ISO |
9 |
63,386,990 |
63,388,747 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest-specific 2 |
|
decreases expression |
ISO |
1 |
101,697,265 |
101,798,495 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
increases expression |
ISO |
15 |
23,023,996 |
23,139,794 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
|
increases expression |
ISO |
5 |
25,809,543 |
26,008,249 |
RGD:6480464 |
CTD |
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
decreases expression |
ISO |
14 |
2,597,303 |
2,606,681 |
RGD:6480464 |
CTD |
| G |
Gla |
galactosidase, alpha |
|
increases expression |
ISO |
X |
122,044,703 |
122,056,327 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
decreases activity |
ISO |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
decreases expression |
ISO |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Gmcl1 |
germ cell-less, spermatogenesis associated 1 |
|
decreases expression |
ISO |
4 |
120,845,606 |
120,885,122 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
increases expression |
ISO |
17 |
66,993,915 |
67,004,339 |
RGD:6480464 |
CTD |
| G |
Gpr155 |
G protein-coupled receptor 155 |
|
decreases expression |
ISO |
3 |
55,846,337 |
55,900,086 |
RGD:6480464 |
CTD |
| G |
Gpr180 |
G protein-coupled receptor 180 |
|
decreases expression |
ISO |
15 |
102,931,713 |
102,955,239 |
RGD:6480464 |
CTD |
| G |
Gpr65 |
G-protein coupled receptor 65 |
|
decreases expression |
ISO |
6 |
122,432,615 |
122,433,628 |
RGD:6480464 |
CTD |
| G |
Gpr84 |
G protein-coupled receptor 84 |
|
decreases expression |
ISO |
7 |
142,217,811 |
142,220,004 |
RGD:6480464 |
CTD |
| G |
Gsap |
gamma-secretase activating protein |
|
decreases expression |
ISO |
4 |
9,306,309 |
9,401,421 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hagh |
hydroxyacyl glutathione hydrolase |
|
decreases expression |
ISO |
10 |
14,106,047 |
14,117,459 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Helz |
helicase with zinc finger |
|
decreases expression |
ISO |
10 |
96,952,234 |
97,091,028 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
decreases expression |
ISO |
1 |
241,736,542 |
241,742,129 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
increases expression |
ISO |
4 |
56,146,654 |
56,147,441 |
RGD:6480464 |
CTD |
| G |
Hipk3 |
homeodomain interacting protein kinase 3 |
|
decreases expression |
ISO |
3 |
89,749,949 |
89,816,787 |
RGD:6480464 |
CTD |
| G |
Hist1h2bd |
histone cluster 1, H2bd |
|
increases expression |
ISO |
17 |
50,429,266 |
50,429,647 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
increases expression |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hist1h3c |
histone cluster 1, H3c |
|
increases expression |
ISO |
17 |
48,514,749 |
48,515,222 |
RGD:6480464 |
CTD |
| G |
Hist2h2bb |
histone cluster 2, H2bb |
|
increases expression |
ISO |
2 |
191,082,471 |
191,089,600 |
RGD:6480464 |
CTD |
| G |
Hist3h2a |
histone cluster 3, H2a |
|
increases expression |
ISO |
10 |
45,245,900 |
45,247,452 |
RGD:6480464 |
CTD |
| G |
Hmga2 |
high mobility group AT-hook 2 |
|
increases expression |
ISO |
7 |
59,638,555 |
59,753,791 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
|
decreases expression |
ISO |
13 |
93,978,865 |
93,987,654 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
decreases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
ISO |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hps3 |
Hermansky-Pudlak syndrome 3 homolog (human) |
|
decreases expression |
ISO |
2 |
105,135,644 |
105,177,925 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
increases expression |
ISO |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
decreases expression |
ISO |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
increases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
increases expression |
ISO |
13 |
70,058,818 |
70,060,910 |
RGD:6480464 |
CTD |
| G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
decreases expression |
ISO |
1 |
238,559,729 |
238,565,793 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
|
increases expression |
ISO |
11 |
81,115,320 |
81,216,170 |
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
decreases expression |
ISO |
1 |
179,911,684 |
179,922,158 |
RGD:6480464 |
CTD |
| G |
Ikbip |
IKBKB interacting protein |
|
decreases expression |
ISO |
7 |
28,020,915 |
28,032,829 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases response to substance |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
increases expression |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
increases response to substance |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
decreases response to substance |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
affects response to substance |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il16 |
interleukin 16 |
|
decreases expression |
ISO |
1 |
139,908,061 |
140,000,146 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
increases expression |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
increases expression |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il17f |
interleukin 17F |
|
increases expression |
ISO |
9 |
19,507,952 |
19,519,338 |
RGD:6480464 |
CTD |
| G |
Il17ra |
interleukin 17 receptor A |
|
increases expression |
EXP |
4 |
156,838,353 |
156,862,345 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
affects response to substance |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il22 |
interleukin 22 |
|
multiple interactions |
ISO |
7 |
57,517,321 |
57,521,786 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
multiple interactions |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
increases expression |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il36rn |
interleukin 36 receptor antagonist |
|
decreases expression |
ISO |
3 |
2,530,402 |
2,536,999 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases secretion |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
multiple interactions |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
affects response to substance |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Impad1 |
inositol monophosphatase domain containing 1 |
|
decreases expression |
ISO |
5 |
18,086,121 |
18,109,691 |
RGD:6480464 |
CTD |
| G |
Irf2 |
interferon regulatory factor 2 |
|
decreases expression |
ISO |
16 |
48,672,930 |
48,725,511 |
RGD:6480464 |
CTD |
| G |
Irg1 |
immunoresponsive gene 1 |
|
increases expression |
ISO |
15 |
87,056,688 |
87,066,471 |
RGD:6480464 |
CTD |
| G |
Itfg1 |
integrin alpha FG-GAP repeat containing 1 |
|
decreases expression |
ISO |
19 |
22,561,637 |
22,682,885 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Jmjd1c |
jumonji domain containing 1C |
|
increases expression |
ISO |
20 |
22,151,774 |
22,283,264 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kif18a |
kinesin family member 18A |
|
decreases expression |
ISO |
3 |
94,825,019 |
94,885,158 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
increases expression |
ISO |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klf3 |
Kruppel-like factor 3 (basic) |
|
increases expression |
ISO |
14 |
46,203,638 |
46,226,077 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
decreases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
increases expression |
ISO |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
increases expression |
ISO |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klhl42 |
kelch-like family, member 42 |
|
decreases expression |
ISO |
4 |
184,688,926 |
184,709,859 |
RGD:6480464 |
CTD |
| G |
Ldhc |
lactate dehydrogenase C |
|
increases expression |
EXP |
1 |
97,418,622 |
97,435,275 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases expression |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lipt2 |
lipoyl(octanoyl) transferase 2 (putative) |
|
decreases expression |
ISO |
1 |
157,538,704 |
157,541,031 |
RGD:6480464 |
CTD |
| G |
Litaf |
lipopolysaccharide-induced TNF factor |
|
increases expression |
ISO |
10 |
4,614,177 |
4,623,903 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
decreases expression |
ISO |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100360950 |
GF20391-like |
|
increases expression |
ISO |
17 |
50,386,764 |
50,411,138 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lrr1 |
leucine rich repeat protein 1 |
|
decreases expression |
ISO |
6 |
91,124,122 |
91,132,796 |
RGD:6480464 |
CTD |
| G |
Lrrc14 |
leucine rich repeat containing 14 |
|
decreases expression |
ISO |
7 |
114,760,919 |
114,766,477 |
RGD:6480464 |
CTD |
| G |
Lrrk1 |
leucine-rich repeat kinase 1 |
|
decreases expression |
ISO |
1 |
120,695,657 |
120,836,324 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
decreases expression |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin beta (TNF superfamily, member 3) |
|
increases expression |
ISO |
20 |
3,666,524 |
3,668,369 |
RGD:6480464 |
CTD |
| G |
Luc7l2 |
LUC7-like 2 (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
66,121,484 |
66,182,237 |
RGD:6480464 |
CTD |
| G |
Luc7l2 |
LUC7-like 2 (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
66,121,484 |
66,182,237 |
RGD:6480464 |
CTD |
| G |
Lyrm2 |
LYR motif containing 2 |
|
decreases expression |
ISO |
5 |
49,094,373 |
49,096,651 |
RGD:6480464 |
CTD |
| G |
Lyrm5 |
LYR motif containing 5 |
|
decreases expression |
ISO |
4 |
182,859,926 |
182,865,036 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
|
decreases expression |
ISO |
19 |
24,711,378 |
24,730,659 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
increases expression |
ISO |
19 |
51,847,187 |
51,854,858 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
affects binding |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mavs |
mitochondrial antiviral signaling protein |
|
decreases expression |
ISO |
3 |
118,938,433 |
118,953,081 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
decreases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdp1 |
magnesium-dependent phosphatase 1 |
|
decreases expression |
ISO |
15 |
33,792,908 |
33,795,806 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
decreases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Metrnl |
meteorin, glial cell differentiation regulator-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mettl21a |
methyltransferase like 21A |
|
decreases expression |
ISO |
9 |
63,245,760 |
63,254,346 |
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mfsd6 |
major facilitator superfamily domain containing 6 |
|
decreases expression |
ISO |
9 |
45,759,998 |
45,845,858 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mina |
myc induced nuclear antigen |
|
increases expression |
ISO |
11 |
41,626,321 |
41,649,489 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
increases expression |
EXP |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mocs2 |
molybdenum cofactor synthesis 2 |
|
decreases expression |
ISO |
2 |
46,948,321 |
46,960,060 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases activity |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mrpl15 |
mitochondrial ribosomal protein L15 |
|
decreases expression |
ISO |
5 |
14,932,623 |
14,943,904 |
RGD:6480464 |
CTD |
| G |
Mrpl50 |
mitochondrial ribosomal protein L50 |
|
decreases expression |
ISO |
5 |
66,261,553 |
66,266,710 |
RGD:6480464 |
CTD |
| G |
Mst1r |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
|
increases expression |
ISO |
8 |
113,175,977 |
113,189,511 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mtmr4 |
myotubularin related protein 4 |
|
decreases expression |
ISO |
10 |
75,883,526 |
75,906,440 |
RGD:6480464 |
CTD |
| G |
Mtmr9 |
myotubularin related protein 9 |
|
decreases expression |
ISO |
15 |
42,787,644 |
42,809,678 |
RGD:6480464 |
CTD |
| G |
Mup1 |
major urinary protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
increases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
increases expression |
EXP |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
multiple interactions |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myo10 |
myosin X |
|
increases expression |
ISO |
2 |
77,183,028 |
77,385,896 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
increases expression |
ISO |
7 |
67,642,321 |
67,648,713 |
RGD:6480464 |
CTD |
| G |
Nabp1 |
nucleic acid binding protein 1 |
|
increases expression |
ISO |
9 |
47,194,891 |
47,201,876 |
RGD:6480464 |
CTD |
| G |
Nanp |
N-acetylneuraminic acid phosphatase |
|
decreases expression |
ISO |
3 |
141,639,178 |
141,651,910 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
decreases expression |
ISO |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
decreases expression |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
increases expression |
EXP |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ndel1 |
nudE nuclear distribution gene E homolog (A. nidulans)-like 1 |
|
increases expression |
ISO |
10 |
55,581,250 |
55,614,926 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
decreases expression |
ISO |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
18 |
61,134,242 |
61,477,040 |
RGD:6480464 |
CTD |
| G |
Nfam1 |
NFAT activating protein with ITAM motif 1 |
|
decreases expression |
ISO |
7 |
121,019,642 |
121,038,935 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
|
increases expression |
ISO |
17 |
18,092,489 |
18,107,708 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects response to substance |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
decreases expression |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
ISO |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Nisch |
nischarin |
|
decreases expression |
ISO |
16 |
6,601,521 |
6,637,734 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
increases expression |
EXP |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nono |
non-POU domain containing, octamer-binding |
|
decreases expression |
ISO |
X |
89,502,318 |
89,520,178 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
decreases expression |
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
|
increases expression |
ISO |
3 |
9,860,524 |
9,877,109 |
RGD:6480464 |
CTD |
| G |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
decreases expression |
ISO |
19 |
44,181,782 |
44,196,976 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
|
decreases expression |
ISO |
9 |
22,233,997 |
22,247,453 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
EXP |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
decreases expression |
ISO |
X |
89,721,369 |
89,766,218 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
decreases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Osbpl9 |
oxysterol binding protein-like 9 |
|
increases expression |
ISO |
5 |
130,409,248 |
130,554,704 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
increases expression |
ISO |
19 |
49,675,215 |
49,690,479 |
RGD:6480464 |
CTD |
| G |
Osgin2 |
oxidative stress induced growth inhibitor family member 2 |
|
increases expression |
ISO |
5 |
30,582,447 |
30,601,332 |
RGD:6480464 |
CTD |
| G |
Oxr1 |
oxidation resistance 1 |
|
decreases expression |
ISO |
7 |
77,427,877 |
77,501,800 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases expression |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
decreases expression |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
decreases expression |
ISO |
7 |
72,116,140 |
72,128,433 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
increases expression |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pank1 |
pantothenate kinase 1 |
|
decreases expression |
ISO |
1 |
238,797,912 |
238,857,586 |
RGD:6480464 |
CTD |
| G |
Paqr7 |
progestin and adipoQ receptor family member VII |
|
decreases expression |
ISO |
5 |
153,263,432 |
153,264,469 |
RGD:6480464 |
CTD |
| G |
Pard6b |
par-6 (partitioning defective 6) homolog beta (C. elegans) |
|
increases expression |
ISO |
3 |
159,230,673 |
159,251,755 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases methylation |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
|
decreases expression |
ISO |
11 |
66,736,902 |
66,768,977 |
RGD:6480464 |
CTD |
| G |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
|
decreases expression |
ISO |
14 |
83,905,714 |
83,936,768 |
RGD:6480464 |
CTD |
| G |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
|
decreases expression |
ISO |
14 |
83,905,714 |
83,936,768 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
decreases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcgf6 |
polycomb group ring finger 6 |
|
decreases expression |
ISO |
1 |
252,357,987 |
252,377,545 |
RGD:6480464 |
CTD |
| G |
Pcm1 |
pericentriolar material 1 |
|
decreases expression |
ISO |
16 |
54,321,572 |
54,419,178 |
RGD:6480464 |
CTD |
| G |
Pcyox1 |
prenylcysteine oxidase 1 |
|
decreases expression |
ISO |
4 |
120,569,436 |
120,580,273 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde7a |
phosphodiesterase 7A |
|
decreases expression |
ISO |
2 |
104,339,910 |
104,429,820 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdik1l |
PDLIM1 interacting kinase 1 like |
|
decreases expression |
ISO |
5 |
153,020,501 |
153,032,221 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
increases expression |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Peg12 |
paternally expressed 12 |
|
decreases expression |
ISO |
1 |
116,710,210 |
116,711,065 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
increases expression |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Phf17 |
PHD finger protein 17 |
|
decreases expression |
ISO |
2 |
128,499,983 |
128,553,050 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
decreases expression |
ISO |
8 |
67,025,248 |
67,123,016 |
RGD:6480464 |
CTD |
| G |
Pigh |
phosphatidylinositol glycan anchor biosynthesis, class H |
|
decreases expression |
ISO |
6 |
101,713,237 |
101,722,655 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
decreases expression |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
increases expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
increases expression |
ISO |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
|
increases expression |
ISO |
1 |
227,689,733 |
227,961,671 |
RGD:6480464 |
CTD |
| G |
Pla2g15 |
phospholipase A2, group XV |
|
decreases expression |
ISO |
19 |
35,997,758 |
36,015,531 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
increases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plek |
pleckstrin |
|
increases expression |
ISO |
14 |
97,841,595 |
97,875,052 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
increases expression |
ISO |
5 |
137,443,540 |
137,448,715 |
RGD:6480464 |
CTD |
| G |
Plxnc1 |
plexin C1 |
|
decreases expression |
ISO |
7 |
31,984,866 |
32,137,758 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
increases expression |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
increases expression |
ISO |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
|
decreases expression |
ISO |
5 |
154,652,576 |
154,655,560 |
RGD:6480464 |
CTD |
| G |
Poli |
polymerase (DNA directed), iota |
|
decreases expression |
ISO |
18 |
67,212,984 |
67,230,580 |
RGD:6480464 |
CTD |
| G |
Polr3g |
polymerase (RNA) III (DNA directed) polypeptide G |
|
decreases expression |
ISO |
2 |
9,763,378 |
9,804,285 |
RGD:6480464 |
CTD |
| G |
Polr3k |
polymerase (RNA) III (DNA directed) polypeptide K |
|
decreases expression |
ISO |
3 |
171,017,930 |
171,022,127 |
RGD:6480464 |
CTD |
| G |
Polrmt |
polymerase (RNA) mitochondrial (DNA directed) |
|
decreases expression |
ISO |
7 |
11,474,465 |
11,484,680 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases expression |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
decreases expression |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Ppargc1b |
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
|
decreases expression |
ISO |
18 |
57,277,749 |
57,301,024 |
RGD:6480464 |
CTD |
| G |
Ppcs |
phosphopantothenoylcysteine synthetase |
|
decreases expression |
ISO |
5 |
140,008,434 |
140,012,295 |
RGD:6480464 |
CTD |
| G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
|
increases expression |
ISO |
20 |
2,940,605 |
2,984,636 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
decreases expression |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
decreases expression |
ISO |
4 |
5,620,992 |
5,667,438 |
RGD:6480464 |
CTD |
| G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I, beta |
|
decreases expression |
ISO |
12 |
16,025,867 |
16,131,129 |
RGD:6480464 |
CTD |
| G |
Procr |
protein C receptor, endothelial |
|
increases expression |
ISO |
3 |
146,268,567 |
146,273,718 |
RGD:6480464 |
CTD |
| G |
Pros1 |
protein S (alpha) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Prpf39 |
PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
86,385,975 |
86,412,072 |
RGD:6480464 |
CTD |
| G |
Prr12 |
proline rich 12 |
|
decreases expression |
ISO |
1 |
95,501,763 |
95,524,511 |
RGD:6480464 |
CTD |
| G |
Prss35 |
protease, serine, 35 |
|
decreases expression |
ISO |
8 |
92,009,530 |
92,025,563 |
RGD:6480464 |
CTD |
| G |
Psen1 |
presenilin 1 |
|
increases expression |
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
decreases expression |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmf1 |
proteasome (prosome, macropain) inhibitor subunit 1 |
|
decreases expression |
ISO |
3 |
142,058,695 |
142,083,908 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
increases expression |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched 1 |
|
decreases expression |
ISO |
17 |
7,088,234 |
7,142,459 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptplad2 |
protein tyrosine phosphatase-like A domain containing 2 |
|
decreases expression |
ISO |
5 |
107,706,535 |
107,732,323 |
RGD:6480464 |
CTD |
| G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
|
decreases expression |
ISO |
4 |
174,376,396 |
174,586,694 |
RGD:6480464 |
CTD |
| G |
Pura |
purine rich element binding protein A |
|
decreases expression |
ISO |
18 |
28,916,722 |
28,925,008 |
RGD:6480464 |
CTD |
| G |
Pus3 |
pseudouridylate synthase 3 |
|
decreases expression |
ISO |
8 |
35,349,230 |
35,351,420 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
increases expression |
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Qser1 |
glutamine and serine rich 1 |
|
decreases expression |
ISO |
3 |
90,095,885 |
90,156,901 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
ISO |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
increases expression |
ISO |
16 |
82,871,002 |
82,895,146 |
RGD:6480464 |
CTD |
| G |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
|
decreases expression |
ISO |
1 |
212,474,632 |
212,482,280 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
decreases expression |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad52 |
RAD52 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
156,281,973 |
156,295,238 |
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
increases expression |
ISO |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
|
decreases expression |
ISO |
3 |
119,735,754 |
119,769,685 |
RGD:6480464 |
CTD |
| G |
Rassf3 |
Ras association (RalGDS/AF-6) domain family member 3 |
|
decreases expression |
ISO |
7 |
60,719,224 |
60,783,887 |
RGD:6480464 |
CTD |
| G |
Rbbp6 |
retinoblastoma binding protein 6 |
|
decreases expression |
ISO |
1 |
181,818,248 |
181,849,942 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
decreases expression |
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
decreases expression |
ISO |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
increases expression |
ISO |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Rbmx |
RNA binding motif protein, X-linked |
|
decreases expression |
ISO |
X |
142,112,807 |
142,119,267 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
11 |
32,386,576 |
32,408,850 |
RGD:6480464 |
CTD |
| G |
Rcan3 |
RCAN family member 3 |
|
decreases expression |
ISO |
5 |
154,209,075 |
154,217,368 |
RGD:6480464 |
CTD |
| G |
Rdh11 |
retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
increases expression |
ISO |
6 |
101,946,431 |
101,962,606 |
RGD:6480464 |
CTD |
| G |
Rdh14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
|
decreases expression |
ISO |
6 |
33,867,711 |
33,872,853 |
RGD:6480464 |
CTD |
| G |
Reep3 |
receptor accessory protein 3 |
|
decreases expression |
ISO |
20 |
22,314,093 |
22,397,087 |
RGD:6480464 |
CTD |
| G |
Rel |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
increases expression |
ISO |
14 |
104,645,370 |
104,671,275 |
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
decreases expression |
ISO |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rfx5 |
regulatory factor X, 5 (influences HLA class II expression) |
|
decreases expression |
ISO |
2 |
189,855,438 |
189,862,953 |
RGD:6480464 |
CTD |
| G |
RGD1306746 |
similar to Hypothetical protein MGC25529 |
|
decreases expression |
ISO |
4 |
120,625,443 |
120,654,118 |
RGD:6480464 |
CTD |
| G |
RGD1563888 |
similar to DNA segment, Chr 16, ERATO Doi 472, expressed |
|
decreases expression |
ISO |
11 |
17,446,314 |
17,476,625 |
RGD:6480464 |
CTD |
| G |
Rgs1 |
regulator of G-protein signaling 1 |
|
increases expression |
ISO |
13 |
58,121,188 |
58,125,514 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
increases expression |
ISO |
13 |
68,807,863 |
68,811,307 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhoc |
ras homolog family member C |
|
increases expression |
ISO |
2 |
200,048,056 |
200,054,107 |
RGD:6480464 |
CTD |
| G |
Rif1 |
RAP1 interacting factor homolog (yeast) |
|
decreases expression |
ISO |
3 |
33,574,934 |
33,624,794 |
RGD:6480464 |
CTD |
| G |
Rin2 |
Ras and Rab interactor 2 |
|
decreases expression |
ISO |
3 |
134,307,538 |
134,503,915 |
RGD:6480464 |
CTD |
| G |
Rit1 |
Ras-like without CAAX 1 |
|
decreases expression |
ISO |
2 |
180,846,683 |
180,859,135 |
RGD:6480464 |
CTD |
| G |
Rmdn1 |
regulator of microtubule dynamics 1 |
|
decreases expression |
ISO |
5 |
34,210,399 |
34,233,936 |
RGD:6480464 |
CTD |
| G |
Rnasel |
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
|
decreases expression |
ISO |
13 |
68,822,013 |
68,829,264 |
RGD:6480464 |
CTD |
| G |
Rpl22 |
ribosomal protein L22 |
|
decreases expression |
ISO |
5 |
169,557,840 |
169,564,566 |
RGD:6480464 |
CTD |
| G |
Rpl30 |
ribosomal protein L30 |
|
decreases expression |
ISO |
7 |
69,886,763 |
69,889,656 |
RGD:6480464 |
CTD |
| G |
Rpl41 |
ribosomal protein L41 |
|
decreases expression |
ISO |
7 |
1,839,972 |
1,840,963 |
RGD:6480464 |
CTD |
| G |
Rreb1 |
ras responsive element binding protein 1 |
|
decreases expression |
ISO |
17 |
33,125,272 |
33,251,491 |
RGD:6480464 |
CTD |
| G |
Rsrc1 |
arginine/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
156,889,768 |
157,213,294 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
increases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
Rwdd3 |
RWD domain containing 3 |
|
decreases expression |
ISO |
2 |
217,738,411 |
217,753,572 |
RGD:6480464 |
CTD |
| G |
Rybp |
RING1 and YY1 binding protein |
|
increases expression |
ISO |
4 |
135,101,700 |
135,153,427 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
increases expression |
EXP |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
EXP |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
decreases expression |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
increases expression |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
increases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sdhaf1 |
succinate dehydrogenase complex assembly factor 1 |
|
decreases expression |
ISO |
1 |
85,267,790 |
85,268,761 |
RGD:6480464 |
CTD |
| G |
Sec63 |
SEC63 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
20 |
46,669,125 |
46,738,077 |
RGD:6480464 |
CTD |
| G |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
|
decreases expression |
ISO |
2 |
180,552,405 |
180,570,359 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
multiple interactions |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sertad1 |
SERTA domain containing 1 |
|
increases expression |
ISO |
1 |
82,565,982 |
82,569,250 |
RGD:6480464 |
CTD |
| G |
Sertad2 |
SERTA domain containing 2 |
|
increases expression |
ISO |
14 |
101,372,813 |
101,445,258 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
decreases expression |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
increases expression |
ISO |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Setdb1 |
SET domain, bifurcated 1 |
|
decreases expression |
ISO |
2 |
190,232,228 |
190,264,309 |
RGD:6480464 |
CTD |
| G |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
|
decreases expression |
ISO |
14 |
83,742,995 |
83,800,287 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
|
decreases expression |
ISO |
6 |
98,306,168 |
98,327,175 |
RGD:6480464 |
CTD |
| G |
Sh3bp5 |
SH3-domain binding protein 5 (BTK-associated) |
|
decreases expression |
ISO |
16 |
6,822,512 |
6,888,922 |
RGD:6480464 |
CTD |
| G |
Shprh |
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
1 |
5,846,062 |
5,922,176 |
RGD:6480464 |
CTD |
| G |
Siae |
sialic acid acetylesterase |
|
decreases expression |
ISO |
8 |
38,854,154 |
38,889,452 |
RGD:6480464 |
CTD |
| G |
Siah2 |
siah E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
2 |
148,022,641 |
148,040,390 |
RGD:6480464 |
CTD |
| G |
Skil |
SKI-like oncogene |
|
increases expression |
ISO |
2 |
116,669,375 |
116,691,472 |
RGD:6480464 |
CTD |
| G |
Sla |
src-like adaptor |
|
decreases expression |
ISO |
7 |
104,153,028 |
104,202,272 |
RGD:6480464 |
CTD |
| G |
Slc15a3 |
solute carrier family 15, member 3 |
|
increases expression |
ISO |
1 |
213,341,322 |
213,356,103 |
RGD:6480464 |
CTD |
| G |
Slc16a7 |
solute carrier family 16, member 7 (monocarboxylic acid transporter 2) |
|
decreases expression |
ISO |
7 |
65,210,148 |
65,313,572 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
increases expression |
ISO |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
|
increases expression |
ISO |
3 |
11,539,415 |
11,549,538 |
RGD:6480464 |
CTD |
| G |
Slc25a37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression |
ISO |
15 |
49,806,324 |
49,846,988 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc5a3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
increases expression |
ISO |
11 |
32,063,275 |
32,065,721 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slfn2 |
schlafen 2 |
|
increases expression |
ISO |
10 |
71,236,408 |
71,242,745 |
RGD:6480464 |
CTD |
| G |
Smc6 |
structural maintenance of chromosomes 6 |
|
decreases expression |
ISO |
6 |
34,710,177 |
34,763,158 |
RGD:6480464 |
CTD |
| G |
Snapap |
SNAP-associated protein |
|
decreases expression |
ISO |
2 |
182,762,310 |
182,764,481 |
RGD:6480464 |
CTD |
| G |
Snapc3 |
small nuclear RNA activating complex, polypeptide 3 |
|
decreases expression |
ISO |
5 |
102,275,379 |
102,302,085 |
RGD:6480464 |
CTD |
| G |
Snx5 |
sorting nexin 5 |
|
decreases expression |
ISO |
3 |
132,778,470 |
132,797,964 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
decreases expression |
ISO |
1 |
245,419,532 |
245,527,846 |
RGD:6480464 |
CTD |
| G |
Spast |
spastin |
|
decreases expression |
ISO |
6 |
20,990,083 |
21,048,692 |
RGD:6480464 |
CTD |
| G |
Spata13 |
spermatogenesis associated 13 |
|
decreases expression |
ISO |
15 |
39,722,469 |
39,849,214 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
decreases expression |
ISO |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
St8sia4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
|
decreases expression |
ISO |
9 |
94,820,275 |
94,859,691 |
RGD:6480464 |
CTD |
| G |
Stambp |
Stam binding protein |
|
decreases expression |
ISO |
4 |
117,766,905 |
117,791,399 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
decreases expression |
ISO |
1 |
139,896,268 |
139,906,134 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat2 |
signal transducer and activator of transcription 2 |
|
multiple interactions |
ISO |
7 |
1,564,385 |
1,580,652 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
multiple interactions |
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Stx17 |
syntaxin 17 |
|
decreases expression |
ISO |
5 |
64,798,013 |
64,854,400 |
RGD:6480464 |
CTD |
| G |
Supt20 |
suppressor of Ty 20 |
|
decreases expression |
ISO |
2 |
143,921,831 |
143,955,032 |
RGD:6480464 |
CTD |
| G |
Syk |
spleen tyrosine kinase |
|
decreases expression |
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
decreases expression |
ISO |
8 |
12,107,144 |
12,117,177 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
decreases expression |
ISO |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tardbp |
TAR DNA binding protein |
|
decreases expression |
ISO |
5 |
165,698,665 |
165,709,531 |
RGD:6480464 |
CTD |
| G |
Tcf25 |
transcription factor 25 (basic helix-loop-helix) |
|
increases expression |
ISO |
19 |
53,700,698 |
53,732,930 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
decreases expression |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tcta |
T-cell leukemia translocation altered |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tfap4 |
transcription factor AP-4 |
|
decreases expression |
ISO |
10 |
11,144,057 |
11,159,763 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
9 |
110,043,164 |
110,052,783 |
RGD:6480464 |
CTD |
| G |
Thap11 |
THAP domain containing 11 |
|
decreases expression |
ISO |
19 |
35,692,222 |
35,694,039 |
RGD:6480464 |
CTD |
| G |
Tia1 |
TIA1 cytotoxic granule-associated RNA binding protein |
|
decreases expression |
ISO |
4 |
120,590,164 |
120,617,530 |
RGD:6480464 |
CTD |
| G |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
|
decreases expression |
ISO |
2 |
225,067,695 |
225,076,898 |
RGD:6480464 |
CTD |
| G |
Timm9 |
translocase of inner mitochondrial membrane 9 homolog (yeast) |
|
decreases expression |
ISO |
6 |
93,218,517 |
93,231,326 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tlcd1 |
TLC domain containing 1 |
|
decreases expression |
ISO |
10 |
64,454,775 |
64,456,808 |
RGD:6480464 |
CTD |
| G |
Tlr13 |
toll-like receptor 13 |
|
increases expression |
EXP |
X |
94,289,915 |
94,293,710 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
increases expression |
EXP |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
decreases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tm9sf2 |
transmembrane 9 superfamily member 2 |
|
decreases expression |
ISO |
15 |
107,228,796 |
107,281,296 |
RGD:6480464 |
CTD |
| G |
Tmem123 |
transmembrane protein 123 |
|
decreases expression |
ISO |
8 |
4,604,130 |
4,632,932 |
RGD:6480464 |
CTD |
| G |
Tmem186 |
transmembrane protein 186 |
|
decreases expression |
ISO |
10 |
7,022,562 |
7,025,880 |
RGD:6480464 |
CTD |
| G |
Tmem206 |
transmembrane protein 206 |
|
decreases expression |
ISO |
13 |
107,387,221 |
107,412,108 |
RGD:6480464 |
CTD |
| G |
Tmem218 |
transmembrane protein 218 |
|
decreases expression |
ISO |
8 |
38,459,286 |
38,474,642 |
RGD:6480464 |
CTD |
| G |
Tmlhe |
trimethyllysine hydroxylase, epsilon |
|
increases expression |
ISO |
20 |
8,623 |
56,125 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
decreases expression |
ISO |
18 |
45,083,452 |
45,126,709 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
decreases expression |
ISO |
18 |
45,083,452 |
45,126,709 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnrc6a |
trinucleotide repeat containing 6a |
|
decreases expression |
ISO |
1 |
181,982,994 |
182,053,510 |
RGD:6480464 |
CTD |
| G |
Tollip |
toll interacting protein |
|
increases expression |
ISO |
1 |
202,008,799 |
202,029,669 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trappc5 |
trafficking protein particle complex 5 |
|
decreases expression |
ISO |
12 |
2,471,219 |
2,474,780 |
RGD:6480464 |
CTD |
| G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
increases expression |
EXP |
9 |
8,175,081 |
8,186,142 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
decreases expression |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trib1 |
tribbles homolog 1 (Drosophila) |
|
increases expression |
ISO |
7 |
96,442,239 |
96,448,785 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
increases expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tsr2 |
TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ttc13 |
tetratricopeptide repeat domain 13 |
|
decreases expression |
ISO |
19 |
54,848,488 |
54,904,567 |
RGD:6480464 |
CTD |
| G |
Ttc30b |
tetratricopeptide repeat domain 30B |
|
decreases expression |
ISO |
3 |
58,601,840 |
58,604,421 |
RGD:6480464 |
CTD |
| G |
Ttll3 |
tubulin tyrosine ligase-like family, member 3 |
|
increases expression |
ISO |
4 |
149,280,690 |
149,282,413 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
decreases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases expression |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
increases expression |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
|
decreases expression |
ISO |
3 |
52,034,539 |
52,191,936 |
RGD:6480464 |
CTD |
| G |
Uchl3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
|
decreases expression |
ISO |
15 |
85,628,490 |
85,670,420 |
RGD:6480464 |
CTD |
| G |
Ulk2 |
Unc-51 like kinase 2 (C. elegans) |
|
decreases expression |
ISO |
10 |
47,931,165 |
48,009,986 |
RGD:6480464 |
CTD |
| G |
Usp12 |
ubiquitin specific peptidase 12 |
|
decreases expression |
ISO |
12 |
8,757,532 |
8,808,106 |
RGD:6480464 |
CTD |
| G |
Vamp4 |
vesicle-associated membrane protein 4 |
|
decreases expression |
ISO |
13 |
78,247,189 |
78,269,770 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases secretion |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vps54 |
vacuolar protein sorting 54 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
14 |
102,018,126 |
102,072,258 |
RGD:6480464 |
CTD |
| G |
Wdr77 |
WD repeat domain 77 |
|
decreases expression |
ISO |
2 |
201,206,860 |
201,216,573 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
decreases expression |
ISO |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-type MMTV integration site family member 2 |
|
increases expression |
ISO |
4 |
43,649,783 |
43,689,596 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
increases expression |
ISO |
10 |
65,427,131 |
65,443,208 |
RGD:6480464 |
CTD |
| G |
Wwc1 |
WW and C2 domain containing 1 |
|
increases expression |
ISO |
10 |
20,750,770 |
20,910,298 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases splicing |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
multiple interactions |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xcr1 |
chemokine (C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
128,612,753 |
128,620,389 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zadh2 |
zinc binding alcohol dehydrogenase, domain containing 2 |
|
decreases expression |
ISO |
18 |
80,613,957 |
80,623,307 |
RGD:6480464 |
CTD |
| G |
Zbtb1 |
zinc finger and BTB domain containing 1 |
|
decreases expression |
ISO |
6 |
98,981,038 |
98,984,303 |
RGD:6480464 |
CTD |
| G |
Zbtb12 |
zinc finger and BTB domain containing 12 |
|
decreases expression |
ISO |
20 |
4,039,186 |
4,048,083 |
RGD:6480464 |
CTD |
| G |
Zc3h11a |
zinc finger CCCH-type containing 11A |
|
increases expression |
ISO |
13 |
46,546,434 |
46,585,149 |
RGD:6480464 |
CTD |
| G |
Zc3h12a |
zinc finger CCCH type containing 12A |
|
increases expression |
ISO |
5 |
144,457,753 |
144,467,275 |
RGD:6480464 |
CTD |
| G |
Zc3h14 |
zinc finger CCCH type containing 14 |
|
decreases expression |
ISO |
6 |
122,919,317 |
122,956,935 |
RGD:6480464 |
CTD |
| G |
Zdhhc2 |
zinc finger, DHHC-type containing 2 |
|
decreases expression |
ISO |
16 |
55,155,221 |
55,225,216 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
increases expression |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfand5 |
zinc finger, AN1-type domain 5 |
|
increases expression |
ISO |
1 |
224,442,733 |
224,448,701 |
RGD:6480464 |
CTD |
| G |
Zfhx4 |
zinc finger homeobox 4 |
|
decreases expression |
ISO |
2 |
98,549,509 |
98,734,901 |
RGD:6480464 |
CTD |
| G |
Zfp148 |
zinc finger protein 148 |
|
decreases expression |
ISO |
11 |
69,103,680 |
69,207,360 |
RGD:6480464 |
CTD |
| G |
Zfp161 |
zinc finger protein 161 |
|
decreases expression |
ISO |
9 |
108,512,808 |
108,514,157 |
RGD:6480464 |
CTD |
| G |
Zfp207 |
zinc finger protein 207 |
|
decreases expression |
ISO |
10 |
68,613,434 |
68,625,197 |
RGD:6480464 |
CTD |
| G |
Zfp238 |
zinc finger protein 238 |
|
decreases expression |
ISO |
13 |
93,345,905 |
93,347,473 |
RGD:6480464 |
CTD |
| G |
Zfp295 |
zinc finger protein 295 |
|
increases expression |
ISO |
11 |
37,960,562 |
37,973,333 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp362 |
zinc finger protein 362 |
|
decreases expression |
ISO |
5 |
148,000,281 |
148,022,124 |
RGD:6480464 |
CTD |
| G |
Zfp386 |
zinc finger protein 386 (Kruppel-like) |
|
decreases expression |
ISO |
6 |
143,311,722 |
143,326,401 |
RGD:6480464 |
CTD |
| G |
Zfp472 |
zinc finger protein 472 |
|
decreases expression |
ISO |
7 |
13,653,039 |
13,661,308 |
RGD:6480464 |
CTD |
| G |
Zfp53 |
zinc finger protein 53 |
|
decreases expression |
ISO |
1 |
59,470,512 |
59,498,681 |
RGD:6480464 |
CTD |
| G |
Zfp61 |
zinc finger protein 61 |
|
decreases expression |
ISO |
1 |
79,504,886 |
79,512,625 |
RGD:6480464 |
CTD |
| G |
Zfp654 |
zinc finger protein 654 |
|
decreases expression |
ISO |
11 |
2,120,729 |
2,123,544 |
RGD:6480464 |
CTD |
| G |
Zfp703 |
zinc finger protein 703 |
|
increases expression |
ISO |
16 |
69,405,004 |
69,409,137 |
RGD:6480464 |
CTD |
| G |
Zfp810 |
zinc finger protein 810 |
|
decreases expression |
ISO |
8 |
21,581,895 |
21,598,594 |
RGD:6480464 |
CTD |
| G |
Zfp871 |
zinc finger protein 871 |
|
decreases expression |
ISO |
7 |
13,432,363 |
13,445,788 |
RGD:6480464 |
CTD |
| G |
Zfp948-ps1 |
zinc finger protein 948, pseudogene 1 |
|
increases expression |
ISO |
1 |
59,575,554 |
59,601,364 |
RGD:6480464 |
CTD |
| G |
Zfp958 |
zinc finger protein 958 |
|
decreases expression |
ISO |
12 |
85,497 |
91,322 |
RGD:6480464 |
CTD |
| G |
Zfyve21 |
zinc finger, FYVE domain containing 21 |
|
decreases expression |
ISO |
6 |
136,603,711 |
136,623,531 |
RGD:6480464 |
CTD |
| G |
Zik1 |
zinc finger protein interacting with K protein 1 homolog (mouse) |
|
decreases expression |
ISO |
1 |
63,239,962 |
63,249,114 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
decreases expression |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Znfx1 |
zinc finger, NFX1-type containing 1 |
|
decreases expression |
ISO |
3 |
158,187,092 |
158,246,947 |
RGD:6480464 |
CTD |
| G |
Znrf2 |
zinc and ring finger 2 |
|
decreases expression |
ISO |
4 |
83,224,883 |
83,361,095 |
RGD:6480464 |
CTD |
| G |
Zyg11b |
zyg-11 family member B, cell cycle regulator |
|
decreases expression |
ISO |
5 |
129,342,838 |
129,394,680 |
RGD:6480464 |
CTD |
quartz
|
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
affects expression |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
affects expression |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
C2cd4b |
C2 calcium-dependent domain containing 4B |
|
increases expression |
EXP |
8 |
72,110,481 |
72,111,976 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
increases expression |
EXP |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
affects expression |
EXP |
4 |
105,850,321 |
105,862,109 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
EXP |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
EXP |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
|
increases expression |
EXP |
1 |
80,070,252 |
80,076,528 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
increases expression |
EXP |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Ch25h |
cholesterol 25-hydroxylase |
|
increases expression |
EXP |
1 |
238,457,017 |
238,458,335 |
RGD:6480464 |
CTD |
| G |
Chia |
chitinase, acidic |
|
increases expression |
EXP |
2 |
201,385,584 |
201,431,777 |
RGD:6480464 |
CTD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
increases expression |
EXP |
15 |
56,104,920 |
56,154,321 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
increases expression |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
EXP |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
increases expression |
EXP |
13 |
86,809,011 |
86,823,599 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
increases expression |
EXP |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
decreases activity |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
|
affects expression |
EXP |
16 |
19,816,321 |
19,824,506 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
increases expression |
EXP |
19 |
39,443,016 |
39,447,566 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
EXP |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Mal2 |
mal, T-cell differentiation protein 2 |
|
affects expression |
EXP |
7 |
90,945,459 |
90,978,439 |
RGD:6480464 |
CTD |
| G |
Mir17-1 |
microRNA mir-17-1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mir26a |
microRNA mir-26a |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Msr1 |
macrophage scavenger receptor 1 |
|
increases expression |
EXP |
16 |
56,278,223 |
56,345,472 |
RGD:6480464 |
CTD |
| G |
Noxo1 |
NADPH oxidase organizer 1 |
|
increases expression |
EXP |
10 |
13,949,293 |
13,953,880 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
affects expression |
EXP |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
affects expression |
EXP |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Retnla |
resistin like alpha |
|
affects expression |
EXP |
11 |
53,205,246 |
53,206,745 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
EXP |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
|
affects expression |
EXP |
11 |
85,878,093 |
85,880,335 |
RGD:6480464 |
CTD |
| G |
Serpina10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
increases expression |
EXP |
6 |
127,887,684 |
127,896,122 |
RGD:6480464 |
CTD |
| G |
Slc26a4 |
solute carrier family 26, member 4 |
|
increases expression |
EXP |
6 |
49,389,212 |
49,427,000 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tiam1 |
T-cell lymphoma invasion and metastasis 1 |
|
increases expression |
EXP |
11 |
30,123,752 |
30,252,936 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases activity |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
|
increases expression |
EXP |
9 |
8,059,023 |
8,065,585 |
RGD:6480464 |
CTD |
Term paths to the root
|